BeOne Medicines, formerly known as BeiGene, is a global oncology company focused on discovering, developing, and commercializing innovative cancer therapies.
$406.96+5.09%
报价 2026-11-06
市值
$43.49B
EV
$30.97B
PE (TTM)
160.5x
预期 PE
–
52 周区间距高点 0.0%
$260.27$406.96
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Medical - Pharmaceuticals| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| ONCBeOne Medicines Ltd. | $43.49B | +5.1% | – | 86.9% | 160.5x | 56.0x | – | |
| DFTXMind Medicine (MindMed) Inc. | $4.47B | +9.6% | -100.0% | 0% | – | – | – | |
| AVLNAvalyn Pharma Inc. Common Stock | $1.29B | +9.3% | – | 0% | – | – | – | |
| LTGOLatigo Biotherapeutics Inc. | $757.9M | -3.2% | – | – | – | – | – | |
| CGEMCullinan Therapeutics, Inc. | $695.1M | +4.7% | +142.3% | 0% | – | – | – | |
| VCREVicore Pharma Holding AB | $293.8M | +3.9% | – | 81% | – | – | – | |
| CUVLClinuvel Pharmaceuticals Ltd. | $257.5M | +1.6% | – | – | – | – | – | |
| HITIHigh Tide Inc. | $234.4M | -6.4% | – | 26.5% | – | – | – | |
| ETRAElectra Therapeutics Inc. | $165.5M | +6.1% | – | – | – | – | – | |
| 同行中位数 | – | – | +21.2% | 0% | – | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。